Rehan Akbani

9PUBLICATIONS
53CO-AUTHORS
Molecular targetsProteomics and metabolomicsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|Feb 09, 2026
High-throughput multi-organ proteomics workflow for drug efficacy and toxicity analysis.

Yun Xiong, Lin Tan, Wai-Kin Chan

|Jan 02, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Natalie L Silver, Jin Dai, Travis D Kerr

|Mar 06, 2025
DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis.

Wei Liu, Jun Li, Yitao Tang

|Feb 05, 2025
Ion suppression correction and normalization for non-targeted metabolomics.

Iqbal Mahmud, Bo Wei, Lucas Veillon

|Sep 03, 2024
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies.

Jun Li, Wei Liu, Kamalika Mojumdar

Pageof 2

Frequent Collaborators

2 joint publications

Han Liang

2 joint publications

Iqbal Mahmud

2 joint publications

Daniel J McGrail

2 joint publications

Philip L Lorenzi